Company Monitoring Page for Shire

latest headlines for company on cafepharma

Takeda breaks into top 20 largest pharmas with Shire merger
Pharmaforum
Wed, 10/9/19 - 10:41 am
Tags:
Takeda, Shire, M&A
Takeda eyes emerging markets asset sale to trim its debt; report
Pharmaforum
Thu, 09/26/19 - 10:45 am
Tags:
Takeda, Shire, M&A, emerging markets, Europe
Takeda staffers accuse drugmaker of favoring Shire employees during merger: report
Fierce Pharma
Fri, 08/2/19 - 12:31 pm
Tags:
Korea, Shire, Takeda, employees, M&A
As Takeda absorbs Shire’s R&D ops, the focus is on replacing a centralized command model with a ‘light touch’ in a restructured global organization
Endpoints
Wed, 07/24/19 - 10:39 am
Tags:
Takeda, Shire, R&D, restructuring, M&A
Takeda Eyes Additional Divestitures to Pare Down Shire Deal Debt
BioSpace
Thu, 07/18/19 - 11:39 am
Tags:
Takeda, Shire, M&A
In $86M IPO pitch, Mirum spells out plans to turn Shire discards into orphan liver drug successes
Endpoints
Mon, 06/24/19 - 11:14 am
Tags:
Mirum, IPOs, Shire, liver disease
Servier, armed with Shire cancer drugs, builds out vision for U.S. future
Fierce Pharma
Fri, 06/7/19 - 12:47 pm
Tags:
Servier, oncology, Shire, M&A
Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal
Fierce Pharma
Thu, 05/9/19 - 11:11 am
Tags:
Takeda, Shire, Novartis, M&A, Xiidra, dry eye disease
Novartis Considers Offer for Takeda Eye-Disease Assets
Bloomberg
Wed, 05/8/19 - 05:25 pm
Tags:
Novartis, Takeda, Shire, eye disease, M&A
Pharma AbbVie, Shire investors agree to settle lawsuit over scuttled tax-inversion deal
Fierce Pharma
Sat, 04/13/19 - 12:18 pm
Tags:
AbbVie, Shire, taxes, tax inversions, M&A
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Wed, 03/6/19 - 09:59 am
Tags:
Massachusetts, Boston, Biogen, Tecfidera, Benepali, Shire, Takeda, Vyvanse, Vertex Pharmaceuticals, Orkambi, Kalydeco, Alexion, Soliris, Strensiq, Sanofi Genzyme, Lantus, Ironwood Pharmaceuticals, Linzess
Case Study: How Shire improved its time-to-market
Pharmaforum
Mon, 02/18/19 - 11:19 am
Tags:
Shire, drug development, time-to-market
Takeda mulling sale of emerging market drugs – report
Pharmaforum
Tue, 01/22/19 - 11:39 am
Tags:
Takeda, Shire, M&A, emerging markets
Takeda’s Shire takeover could herald new era of pharma M&A
Pharmaforum
Wed, 01/9/19 - 09:18 am
Tags:
M&A, Takeda, Shire, taxes, Pfizer
With mega merger season in full swing, Takeda officially swallows Shire
Endpoints
Tue, 01/8/19 - 07:09 pm
Tags:
Takeda, Shire, M&A
Takeda builds arsenal for immuno-oncology research, creates cell therapy group
Endpoints
Thu, 01/3/19 - 11:43 pm
Tags:
Takeda, immuno-oncology, cell therapy, Shire
Shire gears up to battle Allergan's Linzess with new constipation drug Motegrity
Fierce Pharma
Wed, 12/19/18 - 12:25 am
Tags:
Takeda, Shire, Allergan, chronic idiopathic constipation, Motegrity
A last-ditch effort to derail Takeda’s $62B Shire buyout goes down in flames
Endpoints
Wed, 12/5/18 - 09:46 am
Tags:
Takeda, Shire, M&A
Takeda Acquisition Of Shire May Bode Well For R&D Staff
Forbes
Mon, 12/3/18 - 10:05 am
Tags:
Shire, Takeda, R&D, M&A
Takeda ready to dismiss assets for a total $10bn
GoinPharma
Sun, 12/2/18 - 12:35 pm
Tags:
Takeda, Shire, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.